Tab. SR Movex SR
Tablet (Sustained Release) · PO · 200mg / tablet (sustained release) · 1 tablet (sustained release)
৳7
Tab. SR
Movex SR
Aceclofenac
— Opsonin Pharma Ltd.
200mg / tablet (sustained release)
Presentations
Dose rules
No structured dose rules are linked to this brand yet.
Dose reference
Human
Extended release tablet: The recommended dose in adults is one 200 mg Aceclofenac tablet daily or as prescribed by the physician.Film coated tablet: The recommended dose in adults is 100 mg, twice daily.
Clinical notes
Applications:
- Spondylitis
Indication Notes:
Aceclofenac is indicated for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, toothache, trauma and lumbago.
Avoid In:
N/A
Contraindication Notes:
Aceclofenac is contraindicated in patients with known hypersensitivity to it or in whom aspirin or NSAIDs precipitate attacks of asthma.
Aceclofenac is a non-steroidal drug with anti-inflammatory and analgesic properties. It is a potent inhibitor of the enzyme cyclooxygenase, which is involved in the production of prostaglandin. After oral administration, it is rapidly and completely absorbed an unchanged drug.
No significant drug interactions has not been observed but close monitoring of patients is required when it is used with: Lithium and Digoxin: may increase plasma concentration of lithium and digoxin. Diuretics: may interact the activity of diuretics. Anticoagulants: may enhance the activity of anticoagulant. Methotrexate: may increase the plasma level of methotrexate.
Aceclofenac is a non-steroidal drug with anti-inflammatory and analgesic properties. It is a potent inhibitor of the enzyme cyclooxygenase, which is involved in the production of prostaglandin. After oral administration, it is rapidly and completely absorbed an unchanged drug.
The use of Aceclofenac should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.
Caution should be exercised to patients with active or suspected peptic ulcer or gastro-intestinal bleeding moderate to severe hepatic impairment and cardiac or renal impairment. Caution should also be exercised in patients suffering from dizziness or urticaria.
There are no clinical data on the use of Aceclofenac in children.